Harima Chemicals Group, Inc. (TYO:4410)
950.00
+14.00 (1.50%)
May 14, 2026, 3:30 PM JST
Harima Chemicals Group Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 6,264 | 4,746 | 6,851 | 6,300 | 5,366 |
Short-Term Investments | - | - | - | - | 1,264 |
Cash & Short-Term Investments | 6,264 | 4,746 | 6,851 | 6,300 | 6,630 |
Cash Growth | 31.99% | -30.73% | 8.75% | -4.98% | 90.63% |
Receivables | 20,563 | 20,696 | 21,703 | 22,210 | 20,042 |
Inventory | 24,051 | 24,449 | 23,173 | 18,927 | 15,378 |
Other Current Assets | 2,493 | 2,252 | 1,861 | 2,354 | 2,187 |
Total Current Assets | 53,371 | 52,143 | 53,588 | 49,791 | 44,237 |
Property, Plant & Equipment | 33,783 | 32,383 | 28,498 | 27,118 | 23,401 |
Long-Term Investments | 11,083 | 10,324 | 10,895 | 9,643 | 9,584 |
Other Intangible Assets | 4,389 | 4,690 | 4,985 | 5,227 | 712 |
Long-Term Deferred Tax Assets | 259 | 503 | 616 | 658 | 968 |
Other Long-Term Assets | 1 | 1 | 1 | 2 | 3 |
Total Assets | 102,886 | 100,044 | 98,583 | 92,439 | 78,905 |
Accounts Payable | 9,326 | 10,980 | 10,725 | 10,292 | 10,585 |
Accrued Expenses | 82 | 96 | - | 96 | 96 |
Short-Term Debt | 20,976 | 28,071 | 29,925 | 18,349 | 7,724 |
Current Portion of Long-Term Debt | 911 | 395 | 1,322 | 7,099 | 312 |
Current Portion of Leases | 417 | 360 | 401 | 412 | 46 |
Current Income Taxes Payable | 433 | 197 | 340 | 255 | 375 |
Other Current Liabilities | 8,815 | 5,779 | 4,977 | 5,153 | 4,011 |
Total Current Liabilities | 40,960 | 45,878 | 47,690 | 41,656 | 23,149 |
Long-Term Debt | 15,887 | 11,743 | 6,200 | 6,185 | 12,661 |
Long-Term Leases | 2,234 | 1,993 | 1,521 | 1,620 | 758 |
Pension & Post-Retirement Benefits | 32 | 116 | 135 | 103 | 246 |
Long-Term Deferred Tax Liabilities | 1,307 | 1,273 | 1,141 | 1,020 | 859 |
Other Long-Term Liabilities | 961 | 1,033 | 1,016 | 1,037 | 1,128 |
Total Liabilities | 61,381 | 62,036 | 57,703 | 51,621 | 38,801 |
Common Stock | 10,012 | 10,012 | 10,012 | 10,012 | 10,012 |
Additional Paid-In Capital | 8,608 | 8,609 | 9,743 | 9,748 | 9,759 |
Retained Earnings | 17,887 | 16,561 | 16,836 | 19,015 | 19,128 |
Treasury Stock | -1,690 | -1,727 | -1,760 | -1,793 | -964 |
Comprehensive Income & Other | 5,982 | 3,876 | 2,386 | 119 | -1,194 |
Total Common Equity | 40,799 | 37,331 | 37,217 | 37,101 | 36,741 |
Minority Interest | 706 | 677 | 3,663 | 3,717 | 3,363 |
Shareholders' Equity | 41,505 | 38,008 | 40,880 | 40,818 | 40,104 |
Total Liabilities & Equity | 102,886 | 100,044 | 98,583 | 92,439 | 78,905 |
Total Debt | 40,425 | 42,562 | 39,369 | 33,665 | 21,501 |
Net Cash (Debt) | -34,161 | -37,816 | -32,518 | -27,365 | -14,871 |
Net Cash Per Share | -1406.01 | -1559.10 | -1342.44 | -1104.81 | -591.17 |
Filing Date Shares Outstanding | 24.31 | 24.27 | 24.23 | 24.2 | 25.17 |
Total Common Shares Outstanding | 24.31 | 24.27 | 24.23 | 24.2 | 25.17 |
Working Capital | 12,411 | 6,265 | 5,898 | 8,135 | 21,088 |
Book Value Per Share | 1678.37 | 1538.45 | 1535.77 | 1532.95 | 1459.96 |
Tangible Book Value | 36,410 | 32,641 | 32,232 | 31,874 | 36,029 |
Tangible Book Value Per Share | 1497.81 | 1345.17 | 1330.06 | 1316.98 | 1431.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.